Inkasso-Unternehmen kommen ins Spiel, wenn unbezahlte Rechnungen doch noch bezahlt werden sollen. Das Startup ecollect bringt mit einem innovativen Ansatz und dem Einsatz selbst entwickelter Software nun frischen Wind in die traditionelle Dienstleistung.

Die Finnova AG und das Fintech Startup Contovista AG gehen eine Partnerschaft ein, um den Finnova-Banken ein vielfältiges Personal Finance Management (PFM) zu bieten. Die Schwyzer Kantonalbank setzt als erste Finnova-Bank auf den neuen persönlichen Finanzassistenten von Contovista.

Das Start-up VRMandat.com bietet für die Schweizer KMU-Landschaft eine zeitgemässe Alternative zum üblichen Weg der Besetzung von Verwaltungsratsgremien. Im Zentrum steht dabei der Blick auf die Diversifikation, Meinungsvielfalt und Unabhängigkeit in den Boards von kleinen und mittleren Unternehmen sowie Stiftungen. Erste Erfolge haben sich bereits eingestellt.

Nexthink, the unique provider of End-user IT Analytics, today announced 60% year-on-year growth in 2014 and continuing momentum into 2015 with its flagship event Analytics’15.

Mit dem Telekomzentrum ist im Januar die erste unabhängige Telekommunikationsberatung in der Schweiz an den Start gegangen, die sich auf individuelle, auf den Kunden zugeschnittene Telekomanalysen fokussiert. In kurzer Zeit konnte das Startup mehrere hundert Anfragen entgegennehmen.

GlycoVaxyn, a leader in the development of innovative conjugate vaccines, announced that it has received the first milestone in its clinical co-development with Janssen Pharmaceuticals, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson, of the vaccine candidate aimed to prevent infections caused by Extraintestinal Pathogenic Escherichia coli (ExPEC or E. coli).

Green Motion, the Swiss market leader in electric vehicle recharging systems, and cablex have entered into a business partnership aimed at advancing the development of the recharging network in Switzerland with the required quality and efficiency. As a ‘preferred partner’, cablex will install the recharging system, put it into operation and provide 24/7 maintenance throughout Switzerland.

Joiz Global gibt heute seinen ersten deutschen Lizenzvertrag mit der Mediengruppe M. DuMont Schauberg (MDS) bekannt. Die Lösung von joiz Global unterstützt Köln.tv im Aufbau seines interaktiven Programms, welches aus Nachrichten, Sport und Lifestyle-Sendungen besteht. Die joiz Plattform ermöglicht es, für Köln.tv eine dynamische und aktive Community aufzubauen. Die Partnerschaft ist Teil der Video-Offensive von MDS.

AutoScout24 et CashSentinel, la société commercialisant une solution innovante de paiement mobile pour faciliter et sécuriser les transactions financières importantes, ont conclu un accord de partenariat afin de proposer le service CashSentinel à la clientèle d’AutoScout24.

GlobalVision opens an office in Dubai and starts operations with an immersive fly-trough of Dubai with 360° aerial panoramas.

Nach der Inspektion des Reinraums Ende November 2014 hat InnoMedica von Swissmedic die Bewilligung zur Herstellung von Arzneimitteln und zum Grosshandel mit Arzneimitteln für die nächsten 5 Jahre erhalten.

Lausanne-based Novertur announces an agreement for a pilot project with Switzerland Global Enterprise (S-GE) for the use of its patent-pending business matchmaking technology. S-GE, which initially supported the collaboration project between Novertur and HE-Arc, is now the first client of the automated trade partner identification tool, specifically designed for trade promotion agencies.

Alpine Institute for Drug Discovery (AIDD) and University of Geneva have received a 238’000 CHF grant from the Swiss Commission for Technology and Innovation (CTI) to pursue early stage research on a novel undisclosed target addressing unmet needs in inflammation using a novel and unique multi-dimensional approach.

AC Immune SA today announced it has entered into a worldwide exclusive license agreement and research collaboration  with Janssen Pharmaceuticals, Inc., to develop and commercialize therapeutic anti-Tau vaccines for the treatment of Alzheimer’s disease and potentially other tauopathies.

The revolutionary PHABLE photolithograhy technology for low-cost printing of photonic patterns is continuing to attract interest from the industry and research fields. The latest example is a China based manufacturer of specialty optical components.

ARKTIS Radiation Detectors is developing their next generation MODES_SNM System that provides a step change in capability. The system currently tested by customs organisations will integrate software developed by the University of Padua.

Silent Circle today announced that its Board of Directors has appointed F. William "Bill" Conner as Chief Executive Officer and member of the Board of Directors effective immediately. As CEO of Silent Circle, Conner also joins the Board of Directors of Blackphone.

SELFRAG AG, specialists in high voltage fragmentation and headquartered in Kerzers, Switzerland, has developed a ground-breaking process for the commercial recycling of incinerator slag. The first system will be installed in Posieux, Canton Fribourg, and will ready for operation at the beginning of 2016.

Switzerland’s Mr Ironman, and the first man to ever win a specific Ironman competition seven times in a row has joined SenseCore’s human high performance team.

Seit vergangener Woche ist das erste BLT-Tram mit dem News- und Info-System passengertv unterwegs. Damit ist der Startschuss für die Ausrüstung der Flotte der BLT Baselland Transport AG gefallen. Auf den Screens des Schweizer Marktleaders passengertv läuft das meistverbreitete Infosystem für den öV, das es in der Schweiz heute gibt.

Tiziana Life Sciences plc, the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, and Novimmune SA announced that they have entered into an agreement under which Novimmune grants Tiziana an exclusive license for the clinical development and commercialization of foralumab, a fully human antihuman CD3 receptor monoclonal antibody. Under the terms of the agreement Novimmune will receive an upfront payment and is eligible to receive clinical milestones and royalties on sales.

Bosch Software Innovations, the Bosch Group’s software and systems house, and KNIME.com, a Swiss start-up and provider of the only open platform for data-driven innovation, today announced that they will work together to allow data mining and data analytics for Internet of Things (IoT) applications.

STEMMER IMAGING has signed an agreement with Optotune AG for the distribution of Optotune’s range of polymer lenses for industrial vision applications.

Neurimmune’s recombinant human monoclonal antibody Aducanumab / BIIB037 reduced beta-amyloid levels in the brain, and had an effect on cognition in patients with prodromal or mild Alzheimer’s disease. These study results were observed in a prespecified interim analysis of the Phase 1b trial conducted by Neurimmune’s collaboration partner Biogen Idec, Cambridge, MA.

PrivaSphere is teaming up with Docsafe by Swisscom to enhance services related to the secure exchange of data. Registered secure e-mails and confidential messages delivered via PrivaSphere’s delivery platform can now be saved and managed in Docsafe as signed PDF files. This means that users can access their secure documents at any time and from anywhere.

Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has become the first company to achieve both ISO 13485 and ISO 27001 certification for its commitment to safe data handling and security.

Anergis, a company developing proprietary ultra-fast allergy vaccines, today announced the start of a Phase II trial designed to finalize the dose selection for the Phase III study of AllerT. AllerT is Anergis´ lead vaccine against birch pollen allergy.

VAXIMM AG, a Swiss-German biotech company focusing on oral cancer vaccines, announced today follow-on data from the first clinical trial of its investigational oral T-cell vaccine VXM01. Data show that the safety profile to date is manageable, and indicate that VXM01 has a potential to trigger a strong targeted T-cell-mediated immune response in pancreatic cancer patients.

Arktis Radiation Detectors enters a new application field. The company announced that it will supply a custom version of its FLASH Radiation Portal Monitors to Swiss Steel AG, a specialist steel manufacturer in Switzerland for the automotive, machine and appliance industry.

Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Vesimune for the treatment of carcinoma in situ (CIS) in the bladder.

Zkipster named a series of leaders from media, entertainment, technology, and management companies to its advisory board. The new board will guide zkipster’s rapid growth, advise on technological developments, and help identify and maximize new markets. One of the new Advisory Board Members is Hans-Jürg (Schoscho) Rufener.

Fitaborate has developed a solution for working out from home. The start-up is the only Swiss company selected for the Seedcamp Week Berlin.

È la start-up Ecker Technologies con il progetto Gondola, presentato da Francesco Cecchini, che si è aggiudicata il premio da CHF 50'000 della StartCup Ticino 2014, la competizione che intende premiare le idee imprenditoriali e i progetti più innovativi e promettenti ideati negli ultimi cinque anni nella Svizzera italiana.

Sierre Energie et énergies sion région rejoignent le plus vaste réseau de recharge pour véhicules électriques de Suisse en installant des bornes publiques à Sion et à Sierre.

BioVersys together with the University of Lille announced today that the company has reached the first milestone in their collaboration with GlaxoSmithKline (GSK). The collaboration was agreed in May 2014 and aims to develop an effective treatment against tuberculosis (TB). As a result, the collaboration will now move into the second stage which is to develop a preclinical candidate.   

Good news from PB&B: The biotech company developing biodegradable microspheres for natural anti-aging Aesthetics has closed a first seed financing round. In addition the company has been awarded with the Trophée de l'Innovation 2014 of the University Hospitals Geneva (HUG).

Viewster is ranked No. 37 fastest growing tech company 2014 in Deloitte's EMEA Fast 500 ranking 2014. This ranking is an important technology awards program in Europe, Middle East & Africa (EMEA).

Depuis février 2014, un module eSMART équipe le 3e étage du bâtiment des Services industriels à la place Chauderon 25. Initié par Xavier Righetti, ingénieur de la division «Développement» du service commercial des SiL, ce projet a permis de tester l’intégration des outils modernes de domotique dans des bâtiments anciens.

GeNeuro SA, a pioneer of new therapies for neurology and autoimmune disorders, announced today that it has entered into a strategic partnership with Servier, the leading independent French pharmaceutical company, to develop and market GNbAC1 in Multiple Sclerosis (MS). As the first drug addressing a causal factor of the disease, GNbAC1 has the potential to radically change the way MS patients are treated.

La 4ème Edition du Meilleur du Web s’est tenue le mecredi 26 novembre à la Fédération des Entreprises Romandes (FER) à Genève. Devant un public enthousiaste, 9 cubes ont été distribués aux lauréats.

Enamine Ltd. and BioVersys AG announced today the extension of their drug discovery collaboration. Enamine has expanded its team of medicinal chemists to support the collaboration. Financial details were not disclosed.

Index Ventures today announced its new €400m ($550M) early stage fund both to invest in and support passionate and ambitious entrepreneurs looking to build the S&P 500 of the next 20 years.

easySYS, die cloudbasierte Business Software der St.Galler Firma iBROWS, ist letztes Jahr erneut stark gewachsen. easySYS wird deshalb vom Gründerteam in eine eigene AG umgewandelt und holt sich mit Martin Altorfer weitere Verstärkung an Bord.

SonarSource provides applications and services for continuous inspection of code quality. The company has today more than 200 customers worldwide and 25 employees, and still growing.

Die Ende Juni lancierte Crowdfunding-Plattform www.ibeliveinyou.ch konnte in den ersten vier Monaten bereits 34 Schweizer Sport-Projekte finanzieren. Die Gesamtfördersumme von 175'000 Franken liegt über den Erwartungen der Initianten. In den kommenden Monaten wird die Plattform auch in der Romandie und dem Tessin gestartet.

Botulinum toxin dilution is a recurrent problem and the focus of an outstanding number of discussions, courses and ultimately mistakes. Primequal has developed a new generation of Talent BT injection systems that deliver botulinum toxin in units and therefore solves dilution problems.

In October Loylogic launched PointsPay, a scalable, solution which allows users to pay with their points and miles at several million point of sales. In the first month since public launch, PointsPay shows a rapid upswing of user adoption.

Ringier is the largest internationally operating Swiss media company, with approximately 8,000 employees. The company selected Symfact as Ringiers standard platform for both Contract Management and control of companies’ structures, subsidiaries and more.

Spectraseis, a technology leader in microseismic fracture monitoring and stimulation evaluation, today announced the achievement of important technical and commercial milestones, which have positioned the company for exceptional growth in 2012. These include the successful delivery of fracture monitoring results with the company’s new high-sensitivity, three-component (3-C) surface and borehole microseismic arrays in the US and Canadaa and Spectraseis’ 70th patent filing.

2011 war ein weiteres gutes Jahr für BLACKSOCKS, den Erfinder des Socken-Abos.Der Umsatz ist wie in den Vorjahren im zweistelligen Bereich gewachsen.